We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » iRhythm Technologies Rapped for Failing to Take Corrective Actions, Other Issues with Cardiac Monitoring System
iRhythm Technologies Rapped for Failing to Take Corrective Actions, Other Issues with Cardiac Monitoring System
An FDA inspection of an iRhythm Technologies facility in Irvine, Calif., resulted in a Form 483 to the firm for not establishing corrective and preventative actions, not submitting a medical device report (MDR), and other issues regarding the company’s cardiac monitoring system.